University of Hertfordshire

From the same journal

By the same authors

Concurrent participation in screening for cervical, breast, and bowel cancer in England

Research output: Contribution to journalArticlepeer-review

Standard

Concurrent participation in screening for cervical, breast, and bowel cancer in England. / Rebolj, Matejka; Parmar, Dharmishta; Maroni, Roberta; Blyuss, Oleg; Duffy, Stephen W.

In: Journal of Medical Screening, 16.09.2019, p. 1-9.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Rebolj, Matejka ; Parmar, Dharmishta ; Maroni, Roberta ; Blyuss, Oleg ; Duffy, Stephen W. / Concurrent participation in screening for cervical, breast, and bowel cancer in England. In: Journal of Medical Screening. 2019 ; pp. 1-9.

Bibtex

@article{444b9874010f458e9ade2f353918865c,
title = "Concurrent participation in screening for cervical, breast, and bowel cancer in England",
abstract = "Objectives: To determine how many women participate in all three recommended cancer screening programmes (breast, cervical, and bowel). During their early 60s, English women receive an invitation from all the three programmes. Methods: For 3060 women aged 60–65 included in an England-wide breast screening case–control study, we investigated the number of screening programmes they participated in during the last invitation round. Additionally, using the Fingertips database curated by Public Health England, we explored area-level correlations between participation in the three cancer screening programmes and various population characteristics for all 7014 English general practices with complete data. Results: Of the 3060 women, 1086 (35%) participated in all three programmes, 1142 (37%) in two, 526 (17%) in one, and 306 (10%) in none. Participation in all three did not appear to be a random event (p < 0.001). General practices from areas with less deprivation, with more patients who are carers or have chronic illnesses themselves, and with more patients satisfied with the provided service were significantly more likely to attain high coverage rates in all programmes. Conclusions: Only a minority of English women is concurrently protected through all recommended cancer screening programmes. Future studies should consider why most women participate in some but not all recommended screening.",
keywords = "Breast cancer, bowel cancer, cervical cancer, participation, screening",
author = "Matejka Rebolj and Dharmishta Parmar and Roberta Maroni and Oleg Blyuss and Duffy, {Stephen W}",
year = "2019",
month = sep,
day = "16",
doi = "10.1177/0969141319871977",
language = "English",
pages = "1--9",
journal = "Journal of Medical Screening",
issn = "0969-1413",
publisher = "SAGE Publications Ltd",

}

RIS

TY - JOUR

T1 - Concurrent participation in screening for cervical, breast, and bowel cancer in England

AU - Rebolj, Matejka

AU - Parmar, Dharmishta

AU - Maroni, Roberta

AU - Blyuss, Oleg

AU - Duffy, Stephen W

PY - 2019/9/16

Y1 - 2019/9/16

N2 - Objectives: To determine how many women participate in all three recommended cancer screening programmes (breast, cervical, and bowel). During their early 60s, English women receive an invitation from all the three programmes. Methods: For 3060 women aged 60–65 included in an England-wide breast screening case–control study, we investigated the number of screening programmes they participated in during the last invitation round. Additionally, using the Fingertips database curated by Public Health England, we explored area-level correlations between participation in the three cancer screening programmes and various population characteristics for all 7014 English general practices with complete data. Results: Of the 3060 women, 1086 (35%) participated in all three programmes, 1142 (37%) in two, 526 (17%) in one, and 306 (10%) in none. Participation in all three did not appear to be a random event (p < 0.001). General practices from areas with less deprivation, with more patients who are carers or have chronic illnesses themselves, and with more patients satisfied with the provided service were significantly more likely to attain high coverage rates in all programmes. Conclusions: Only a minority of English women is concurrently protected through all recommended cancer screening programmes. Future studies should consider why most women participate in some but not all recommended screening.

AB - Objectives: To determine how many women participate in all three recommended cancer screening programmes (breast, cervical, and bowel). During their early 60s, English women receive an invitation from all the three programmes. Methods: For 3060 women aged 60–65 included in an England-wide breast screening case–control study, we investigated the number of screening programmes they participated in during the last invitation round. Additionally, using the Fingertips database curated by Public Health England, we explored area-level correlations between participation in the three cancer screening programmes and various population characteristics for all 7014 English general practices with complete data. Results: Of the 3060 women, 1086 (35%) participated in all three programmes, 1142 (37%) in two, 526 (17%) in one, and 306 (10%) in none. Participation in all three did not appear to be a random event (p < 0.001). General practices from areas with less deprivation, with more patients who are carers or have chronic illnesses themselves, and with more patients satisfied with the provided service were significantly more likely to attain high coverage rates in all programmes. Conclusions: Only a minority of English women is concurrently protected through all recommended cancer screening programmes. Future studies should consider why most women participate in some but not all recommended screening.

KW - Breast cancer

KW - bowel cancer

KW - cervical cancer

KW - participation

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=85073986502&partnerID=8YFLogxK

U2 - 10.1177/0969141319871977

DO - 10.1177/0969141319871977

M3 - Article

C2 - 31525303

SP - 1

EP - 9

JO - Journal of Medical Screening

JF - Journal of Medical Screening

SN - 0969-1413

ER -